相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。LECT2 as a hepatokine links liver steatosis to inflammation via activating tissue macrophages in NASH
Noboru Takata et al.
SCIENTIFIC REPORTS (2021)
Leukocyte cell-derived chemotaxin 2 promotes the development of nonalcoholic fatty liver disease through STAT-1 pathway in mice
Jinghua Wang et al.
LIVER INTERNATIONAL (2021)
Sinularin, an Anti-Cancer Agent Causing Mitochondria-Modulated Apoptosis and Cytoskeleton Disruption in Human Hepatocellular Carcinoma
Chou-Yuan Ko et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Microalgal extract from thermotolerant Coelastrella sp. F50 retards the liver tumor progression by targeting hepatic cancer stem cells
Yi-Chen Chang et al.
PHYTOTHERAPY RESEARCH (2021)
Cancer stem cells in hepatocellular carcinoma - from origin to clinical implications
Terence Kin-Wah Lee et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
The Cancer Stem Cell in Hepatocellular Carcinoma
Lucas-Alexander Schulte et al.
CANCERS (2020)
Cancer Stem Cell Functions in Hepatocellular Carcinoma and Comprehensive Therapeutic Strategies
Yu-Chin Liu et al.
CELLS (2020)
Cancer Stem Cells and Its Role in Angiogenesis and Vasculogenic Mimicry in Gastrointestinal Cancers
Erik Lizarraga-Verdugo et al.
FRONTIERS IN ONCOLOGY (2020)
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Pedro M. Folegatti et al.
LANCET (2020)
Hepatoma-derived growth factor participates in concanavalin A-induced hepatitis
E-Ming Wang et al.
FASEB JOURNAL (2020)
AKT/GSK-3β/β-catenin signaling pathway participates in erythropoietin-promoted glioma proliferation
Zhaohua Tang et al.
JOURNAL OF NEURO-ONCOLOGY (2020)
Targeting epithelial-mesenchymal transition pathway in hepatocellular carcinoma
Jaewhan Song
CLINICAL AND MOLECULAR HEPATOLOGY (2020)
Regorafenib Versus Nivolumab After Sorafenib Failure: Real-World Data in Patients With Hepatocellular Carcinoma
Won-Mook Choi et al.
HEPATOLOGY COMMUNICATIONS (2020)
Emerging Mechanisms by which EMT Programs Control Stemness
Molly M. Wilson et al.
TRENDS IN CANCER (2020)
Lect2 Controls Inflammatory Monocytes to Constrain the Growth and Progression of Hepatocellular Carcinoma
Antoine L'Hermitte et al.
HEPATOLOGY (2019)
Hepatoma-derived growth factor participates in Helicobacter Pylori-induced neutrophils recruitment, gastritis and gastric carcinogenesis
Tian-Huei Chu et al.
ONCOGENE (2019)
LECT2, a Ligand for Tie1, Plays a Crucial Role in Liver Fibrogenesis
Meng Xu et al.
CELL (2019)
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Jorge A. Marrero et al.
HEPATOLOGY (2018)
Celecoxib enhances the therapeutic efficacy of epirubicin for Novikoff hepatoma in rats
Tian-Huei Chu et al.
CANCER MEDICINE (2018)
Leukocyte Cell-Derived Chemotaxin 2 Retards Non-Small Cell Lung Cancer Progression Through Antagonizing MET and EGFR Activities
Wen-Yueh Hung et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Shp2 Promotes Liver Cancer Stem Cell Expansion by Augmenting β-Catenin Signaling and Predicts Chemotherapeutic Response of Patients
Daimin Xiang et al.
HEPATOLOGY (2017)
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Jordi Bruix et al.
LANCET (2017)
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
Anthony B. El-Khoueiry et al.
LANCET (2017)
Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance
Ruth C. R. Meex et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
New knowledge of the mechanisms of sorafenib resistance in liver cancer
Yan-jing Zhu et al.
ACTA PHARMACOLOGICA SINICA (2017)
Leukocyte chemotactic factor 2 amyloidosis (ALECT2) is a common form of renal amyloidosis among Egyptians
Christopher P. Larsen et al.
MODERN PATHOLOGY (2016)
Hepatoma-derived growth factor/nucleolin axis as a novel oncogenic pathway in liver carcinogenesis
San-Cher Chen et al.
ONCOTARGET (2015)
Leukocyte cell-derived chemotaxin 2 (LECT2)-associated amyloidosis is a frequent cause of hepatic amyloidosis in the United States
Oana M. Mereuta et al.
BLOOD (2014)
LECT2 Functions as a Hepatokine That Links Obesity to Skeletal Muscle Insulin Resistance
Fei Lan et al.
DIABETES (2014)
Leukocyte Cell-Derived Chemotaxin 2 Antagonizes MET Receptor Activation to Suppress Hepatocellular Carcinoma Vascular Invasion by Protein Tyrosine Phosphatase 1B Recruitment
Chi-Kuan Chen et al.
HEPATOLOGY (2014)
Multifaceted roles of GSK-3 and Wnt/beta-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention
J. A. McCubrey et al.
LEUKEMIA (2014)
Tackling the cancer stem cells - what challenges do they pose?
Diwakar R. Pattabiraman et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Celecoxib suppresses hepatoma stemness and progression by up-regulating PTEN
Tian-Huei Chu et al.
ONCOTARGET (2014)
PTEN overexpression attenuates angiogenic processes of endothelial cells by blockade of endothelin-1/endothelin B receptor signaling
Hsiao-Mei Kuo et al.
ATHEROSCLEROSIS (2012)
Dickkopf 4 positively regulated by the thyroid hormone receptor suppresses cell invasion in human hepatoma cells
Chen-Hsin Liao et al.
HEPATOLOGY (2012)
Oncogenic β-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in mice
Marie Anson et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
The tumor suppressor function of LECT2 in human hepatocellular carcinoma makes it a potential therapeutic target
H. T. Ong et al.
CANCER GENE THERAPY (2011)
Targeting Wnt Signaling in Colon Cancer Stem Cells
E. Melo Felipe de Sousa et al.
CLINICAL CANCER RESEARCH (2011)
c-Met Is a Marker of Pancreatic Cancer Stem Cells and Therapeutic Target
Chenwei Li et al.
GASTROENTEROLOGY (2011)
Rapid induction of orthotopic hepatocellular carcinoma in immune-competent rats by non-invasive ultrasound-guided cells implantation
Hoi-Hung Chan et al.
BMC GASTROENTEROLOGY (2010)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Polycystin-1 C-terminal tail associates with β-catenin and inhibits canonical Wnt signaling
Mark Lal et al.
HUMAN MOLECULAR GENETICS (2008)
Deficiency of Mbd2 attenuates Wnt signaling
Toby J. Phesse et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Nuclear epidermal growth factor receptor (EGFR) interacts with signal transducer and activator of transcription 5 (STAT5) in activating Aurora-A gene expression
Liang-Yi Hung et al.
NUCLEIC ACIDS RESEARCH (2008)
Akt/protein kinase B activation by adenovirus vectors contributes to NFκB-dependent CXCL10 expression
Q Liu et al.
JOURNAL OF VIROLOGY (2005)
Increase in hepatic NKT cells in leukocyte cell-derived chemotaxin 2-deficient mice contributes to severe concanavalin A-induced hepatitis
T Saito et al.
JOURNAL OF IMMUNOLOGY (2004)
Identification of the leukocyte cell-derived chemotaxin 2 as a direct target gene of β-catenin in the liver
C Ovejero et al.
HEPATOLOGY (2004)
分享论文
